YU135575A - Process for obtsining new compounds of the ergoline structure - Google Patents

Process for obtsining new compounds of the ergoline structure

Info

Publication number
YU135575A
YU135575A YU01355/75A YU135575A YU135575A YU 135575 A YU135575 A YU 135575A YU 01355/75 A YU01355/75 A YU 01355/75A YU 135575 A YU135575 A YU 135575A YU 135575 A YU135575 A YU 135575A
Authority
YU
Yugoslavia
Prior art keywords
obtsining
new compounds
ergoline
ergoline structure
compounds
Prior art date
Application number
YU01355/75A
Other languages
English (en)
Inventor
E Mago
J Bori
E Csanyi
K Pik
L Wolf
Original Assignee
Richter Gedeon Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszet filed Critical Richter Gedeon Vegyeszet
Publication of YU135575A publication Critical patent/YU135575A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
YU01355/75A 1974-05-28 1975-05-25 Process for obtsining new compounds of the ergoline structure YU135575A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HUGO1272A HU169073B (xx) 1974-05-28 1974-05-28

Publications (1)

Publication Number Publication Date
YU135575A true YU135575A (en) 1982-06-30

Family

ID=10996767

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01355/75A YU135575A (en) 1974-05-28 1975-05-25 Process for obtsining new compounds of the ergoline structure

Country Status (21)

Country Link
US (1) US4005089A (xx)
JP (1) JPS5218718B2 (xx)
AT (1) AT346501B (xx)
BE (1) BE829518A (xx)
BG (1) BG27374A3 (xx)
CA (1) CA1051878A (xx)
CS (1) CS194227B2 (xx)
DD (1) DD121639A5 (xx)
DE (1) DE2523743A1 (xx)
DK (1) DK143801C (xx)
ES (1) ES437994A1 (xx)
FI (1) FI61897C (xx)
FR (1) FR2272671B1 (xx)
GB (1) GB1474337A (xx)
HU (1) HU169073B (xx)
IL (1) IL47361A (xx)
NL (1) NL7506276A (xx)
PL (1) PL98944B1 (xx)
SE (1) SE419548B (xx)
SU (1) SU625612A3 (xx)
YU (1) YU135575A (xx)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064249A (en) * 1974-05-28 1977-12-20 Richter Gedeon Vegyeszeti Gyar Rt. Compounds with ergoline skeleton
HU172649B (hu) * 1975-04-24 1978-11-28 Gyogyszerkutato Intezet Sposob poluchenija novykh biologicheski aktivnykh lizergamidov
HU172479B (hu) * 1976-03-09 1978-09-28 Gyogyszerkutato Intezet Sposob poluchenija novykh soedinenij s ehrgolenovymi i
JPS577172Y2 (xx) * 1977-03-17 1982-02-10
JPS582957U (ja) * 1981-06-30 1983-01-10 松下電子工業株式会社 高圧ナトリウムランプ
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
DD238051A1 (de) * 1985-06-10 1986-08-06 Dresden Arzneimittel Verfahren zur herstellung neuer lysergsaeureamide
US8710092B2 (en) * 2009-12-23 2014-04-29 Map Pharmaceuticals, Inc. Substituted indolo 4,3 FG quinolines useful for treating migraine
BR112013033339A2 (pt) 2011-06-23 2016-08-16 Map Pharmaceuticals Inc análogos de fluorergolina
SG11201403434YA (en) 2011-12-19 2014-09-26 Map Pharmaceuticals Inc Novel iso-ergoline derivatives
EP2793583A4 (en) 2011-12-21 2015-08-12 Map Pharmaceuticals Inc NOVEL NEUROMODULATORY CONNECTIONS
US9012640B2 (en) 2012-06-22 2015-04-21 Map Pharmaceuticals, Inc. Cabergoline derivatives
BR112017015487A2 (pt) 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
BR112019025420A2 (pt) 2017-06-01 2020-06-16 Xoc Pharmaceuticals, Inc. Compostos policíclicos e usos destes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2533699A (en) * 1950-12-12 Amines containing the king system
US2673850A (en) * 1951-07-28 1954-03-30 Sandoz Ag Piperazides of the lysergic acid series
US2946796A (en) * 1958-10-15 1960-07-26 Grace W R & Co Salts of ergot alkaloids
CH475252A (de) * 1966-02-08 1969-07-15 Sandoz Ag Verfahren zur Herstellung neuer Lysergsäure-Derivate
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
US3901893A (en) * 1970-05-18 1975-08-26 Richter Gedeon Vegyeszet New dihydro-lysergic acid derivative
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation

Also Published As

Publication number Publication date
NL7506276A (nl) 1975-12-02
ATA386375A (de) 1978-03-15
IL47361A0 (en) 1975-07-28
BG27374A3 (en) 1979-10-12
DD121639A5 (xx) 1976-08-12
DK143801C (da) 1982-03-22
FI61897B (fi) 1982-06-30
SE7505974L (sv) 1975-12-01
FR2272671B1 (xx) 1978-10-06
FI61897C (fi) 1982-10-11
CS194227B2 (en) 1979-11-30
GB1474337A (en) 1977-05-25
JPS5218718B2 (xx) 1977-05-24
CA1051878A (en) 1979-04-03
DK143801B (da) 1981-10-12
ES437994A1 (es) 1977-01-16
FR2272671A1 (xx) 1975-12-26
PL98944B1 (pl) 1978-05-31
HU169073B (xx) 1976-09-28
AU8142575A (en) 1976-11-25
FI751537A (xx) 1975-11-29
SE419548B (sv) 1981-08-10
US4005089A (en) 1977-01-25
SU625612A3 (ru) 1978-09-25
IL47361A (en) 1979-11-30
AT346501B (de) 1978-11-10
BE829518A (fr) 1975-09-15
JPS516998A (xx) 1976-01-20
DK235175A (da) 1975-11-29
DE2523743A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
GB1536407A (en) Process for the preparation of bis-indolic compounds
YU37308B (en) Process for obtaining 3-aryloxy-3-phenyl-propylamine compounds
YU145575A (en) Process for obtaining 8-thiomethyl ergoline
YU135575A (en) Process for obtsining new compounds of the ergoline structure
YU39471B (en) Process for the manufactue of new 1-thiazolylimidazolidinones
YU323775A (en) Process for obtaining new cephalosporin compounds
YU197075A (en) Process for obtaining cephalosporinic compounds
IL48062A0 (en) Process for the preparation of metasubstituted halogenophenols
CH613683A5 (en) Process for the preparation of secoprostaglandins
CH614194A5 (en) Process for the preparation of 5-aroyl- and 5-thenoyl-pyrrole compounds
HU171206B (hu) Sposob poluchenija novykh proizvodnykh fenil-piridil-allilamina
GB1519826A (en) Process for the preparation of 11 - hydroxy - 18 - alkylestrane compounds
YU36540B (en) Process for the crystallization of furctose
YU36721B (en) Process for obtaining cycloalkane-zbcthienylurea compounds
ZA75976B (en) Process for the preparation of cis-vincamine
CH612932A5 (en) Process for the preparation of alkylsulphonylphenoxy-propanolamines
IL47849A0 (en) Process for the preparation of poly-(-n-alkyliminoalanes)
CH611273A5 (en) Process for the preparation of novel 3-oxocyclohex-1-en-1-yl- ureas
ZA753469B (en) Process for the preparation of alpha-diol-alpha-dioxo compounds
CH613206A5 (en) Process for the preparation of 1-aminomethyl-6-phenyltriazolobenzodiazepine compounds
YU98775A (en) Process for obtaining cephalosporin compounds
CH611302A5 (en) Process for the preparation of 7-amino-delta3-cephem derivatives
CH614192A5 (en) Process for the preparation of substituted triphenylethylenes
IL48633A (en) Process for the preparation of trichlorothiazole
IL47243A (en) Process for the preparation of 4-hydroxypyrimidines